Field MSL

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

About Acadia PharmaceuticalsAcadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the...

An exciting oncology launch opportunity!Se le sue competenze, la sua esperienza e le sue qualifiche corrispondono a quelle descritte in questa panoramica, non ritardi l'invio della sua candidatura.Senior Medical Science Liaison Manager (F/M/X) ItalyOur client is a pioneering oncology company developing innovative targeted therapies for patients with...

About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. We are developing...

An exciting oncology launch opportunity! Se le sue competenze, la sua esperienza e le sue qualifiche corrispondono a quelle descritte in questa panoramica, non ritardi l'invio della sua candidatura. Senior Medical Science Liaison Manager (F/M/X) Italy Our client is a pioneering oncology company developing innovative targeted therapies for patients with...

Quetzal Therapeutics seeks an experienced Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology trial across Italy and Germany.Il suo CV è pronto? Se sì, e se è convinto/a che questo sia il ruolo giusto per lei, si candidi il prima possibile.This field-based role engages investigators and treatment centres, driving trial...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...